Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: Biometrics. 2011 Mar;67(1):250–259. doi: 10.1111/j.1541-0420.2010.01422.x

Figure 1.

Figure 1

Observed viral load decrease (left) and CD4 increase (right) after treatment initiation in the three PI groups: lopinavir (top), indinavir (middle) and nelfinavir (bottom)